Brief: Kronos Bio Announces FDA Clearance Of IND Application For KB-0742
07/12/2020 13:08
Dec 7 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW
DRUG
(IND) APPLICATION FOR KB-0742, AN ORAL CDK9 INHIBITOR TARGETING
MYC-AMPLIFIED CANCERS
* KRONOS BIO INC - PHASE 1/2 CLINICAL TRIAL TO BEGIN IN Q1
OF 2021
Source text for Eikon: ID:nGNX2hLpXC
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems